Important Information Regarding Rhopressa

Posted in Latest News on June 26, 2018.

During the June 22, 2018 Board of Optometry meeting, the board approved for addition to Rule 64B13-18.002 Formulary of Topical Ocular Pharmaceutical Agents, Rhopressa (netarsudil ophthalmic solution) 0.02%.

Important note, Rhopressa, at this time, cannot be prescribed by certified Optometrists in Florida until the rule has been approved. Once the rule has gone through the approval process, notice will be provided.



More Latest News

Scam Calls
September 25, 2019

Click here for more information regarding scam calls for license holders claiming to be with the Florida Board. Continue reading


Fourth Quarterly Performance Report Released for the 2018-2019 Fiscal Year
August 23, 2019

The Quarterly Performance Report for the fourth quarter of the 2018-2019 fiscal year is now available online. Continue reading